IMTX – immatics n.v. - ordinary shares (US:NASDAQ)

News

Biotech Immatics to raise $125M through ordinary share offering [Seeking Alpha]
Immatics Announces $125 Million Underwritten Offering [Yahoo! Finance]
Immatics Announces $125 Million Underwritten Offering
Immatics (NASDAQ:IMTX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Immatics (NASDAQ:IMTX) had its "buy" rating reaffirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com